GRAL · Healthcare · $6.0B
$140.89+0.55%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“매출은 4,470만 달러로 전년 동기 대비 26% 늘었고, 최근 매출 흐름도 4,100만 달러에서 4,500만 달러로 다시 가속됐어요.”
In the company's words · 2026 2분기 earnings call